Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (73 total)
-
Creator: Fang, Lei, George Karakiulakis, and Michael Roth.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-03-11
Description: The most distinctive comorbidities of 32 non-survivors from a group of 52 intensive care unit patients with novel coronavirus disease 2019 (COVID-19) in the study by Xiaobo Yang and colleagues were cerebrovascular diseases (22%) and diabetes (22%). -
Creator: Fintzi J, Bonnett T, Sweeney DA, Huprikar NA, Ganesan A, Frank MG, McLellan SLF, Dodd LE, Tebas P, Mehta AK.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-08-19
Description: The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) found that remdesivir therapy hastened recovery in patients hospitalized with COVID-19, but the pathway for this improvement was not explored. We investigated how the dynamics of clinical progression…Conservation strategies: This resource contains recommendations facilitating conservation of equipment and supplies during contingency (expected shortages) and crisis (known shortages) capacities and should not be applied as guidance when conventional capacities are available.
-
Creator: Glynn, Judith R.
Subject: General
Item Type: Publication
Date Last Updated: 2020-04-17
Description: The initial estimates of the case fatality rate of coronavirus disease 2019 (COVID-19) from China and the published modelled estimates both show a very strong age-dependence. -
Creator: Goepfert, Paul A., Bo Fu, Anne-Laure Chabanon, Matthew I. Bonaparte, Matthew G. Davis, Brandon J. Essink, Ian Frank, Owen Haney, Helene Janosczyk, Michael C. Keefer, Marguerite Koutsoukos, Murray A. Kimmel, Roger Masotti, Stephen J. Savarino, Lode…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-04-19
Description: CoV2 preS dTM is a stabilised pre-fusion spike protein vaccine produced in a baculovirus expression system being developed against SARS-CoV-2. We present interim safety and immunogenicity results of the first-in-human study of the CoV2 preS dTM… -
Creator: Greinacher, Andreas, Thomas Thiele, Theodore E. Warkentin, Karin Weisser, Paul A. Kyrle, and Sabine Eichinger.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-04-09
Description: Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ChAdOx1… -
Creator: Grillo, Federica, Emanuela Barisione, Lorenzo Ball, Luca Mastracci, and Roberto Fiocca.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-07-28
Description: With the COVID-19 pandemic having reached tremendous proportions, post-mortem series are under the limelight to explain many of the peculiar clinical findings. Pathological descriptions of disease are fundamental for understanding pathogenetic… -
Creator: Gupta, Aakriti, Mahesh V. Madhavan, Timothy J. Poterucha, Ersilia M. DeFilippis, Jessica A. Hennessey, Bjorn Redfors, Christina Eckhardt, Behnood Bikdeli, Jonathan Platt, Ani Nalbandian, Pierre Elias, Matthew J. Cummings, Shayan N. Nouri, Matthew…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-02-26
Description: The coronavirus disease 2019 (COVID-19) can result in a hyperinflammatory state, leading to acute respiratory distress syndrome (ARDS), myocardial injury, and thrombotic complications, among other sequelae. Statins, which are known to have… -
Creator: Hacisuleyman, Ezgi, Caryn Hale, Yuhki Saito, Nathalie E. Blachere, Marissa Bergh, Erin G. Conlon, Dennis J. Schaefer-Babajew, Justin DaSilva, Frauke Muecksch, Christian Gaebler, Richard Lifton, Michel C. Nussenzweig, Theodora Hatziioannou, Paul D.…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-04-21
Description: Emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are of clinical concern. In a cohort of 417 persons who had received the second dose of BNT162b2 (Pfizer–BioNTech) or mRNA-1273 (Moderna) vaccine at least 2 weeks… -
Creator: Ibarrondo, F. Javier, Jennifer A. Fulcher, David Goodman-Meza, Julie Elliott, Christian Hofmann, Mary A. Hausner, Kathie G. Ferbas, Nicole H. Tobin, Grace M. Aldrovandi, and Otto O. Yang.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-07-21
Description: A recent article suggested the rapid decay of anti–SARS-CoV-2 IgG in early infection, but the rate was not described in detail. We evaluated persons who had recovered from Covid-19 and referred themselves to our institution for observational… -
Creator: Joy, Mark, F. D. Richard Hobbs, Dylan McGagh, Oluwafunmi Akinyemi, and Simon de Lusignan.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-08-04
Description: There have been several attempts to predict mortality from COVID-19 in the UK, including calculation of age-based case fatality rates and relative risk (RR) of mortality.